Lite Strategy, Inc. (Nasdaq: LITS) is a pharmaceutical company that has historically developed novel cancer therapies, including voruciclib (oral CDK9 inhibitor) and zandelisib (oral PI3K inhibitor). In fiscal year 2026, it commenced pre-clinical development in nononcologic indications. The company also adopted a Litecoin Treasury Strategy, holding LTC tokens as a primary reserve asset, writing covered call options on LTC holdings, and conducting active capital market operations including a $100 million PIPE and a share repurchase program.
expected 2027-02-02
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-09-28 | 2026-06-30 | 0001193125-26-405328 | EDGAR | 63K words |
| 2025-09-26 | 2025-06-30 | 0001193125-25-220421 | EDGAR | 65K words |
| 2024-09-19 | 2024-06-30 | 0000950170-24-108185 | EDGAR | 66K words |
| 2023-09-26 | 2023-06-30 | 0000950170-23-049927 | EDGAR | 56K words |
| 2022-09-08 | 2022-06-30 | 0000950170-22-018236 | EDGAR | 61K words |
| 2021-09-02 | 2021-06-30 | 0000950170-21-001655 | EDGAR | 64K words |
| 2020-09-09 | 2020-06-30 | 0001193125-20-242169 | EDGAR | 62K words |
| 2019-08-28 | 2019-06-30 | 0001193125-19-232454 | EDGAR | 50K words |
| 2018-08-30 | 2018-06-30 | 0001193125-18-263586 | EDGAR | 45K words |
| 2017-09-05 | 2017-06-30 | 0001193125-17-276135 | EDGAR | 38K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-11-05 | 2026-09-30 | 0001193125-26-449764 | EDGAR | 24K words |
| 2026-02-17 | 2025-12-31 | 0001193125-26-053215 | EDGAR | 27K words |
| 2025-11-14 | 2025-09-30 | 0001193125-25-283111 | EDGAR | 21K words |
| 2025-05-13 | 2025-03-31 | 0000950170-25-070276 | EDGAR | 21K words |
| 2025-02-12 | 2024-12-31 | 0000950170-25-018809 | EDGAR | 21K words |
| 2024-11-12 | 2024-09-30 | 0000950170-24-125328 | EDGAR | 19K words |
| 2024-05-09 | 2024-03-31 | 0000950170-24-056834 | EDGAR | 24K words |
| 2024-02-13 | 2023-12-31 | 0000950170-24-014640 | EDGAR | 22K words |
| 2023-11-09 | 2023-09-30 | 0000950170-23-061976 | EDGAR | 21K words |
| 2023-05-11 | 2023-03-31 | 0000950170-23-021179 | EDGAR | 27K words |
| 2023-02-09 | 2022-12-31 | 0000950170-23-002323 | EDGAR | 22K words |
| 2022-11-14 | 2022-09-30 | 0000950170-22-024967 | EDGAR | 23K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-11-03 | 0001193125-26-445292 | EDGAR | 1K words |
| 2026-07-30 | 0001193125-26-325026 | EDGAR | 1K words |
| 2026-07-24 | 0001193125-26-316284 | EDGAR | 2K words |
| 2026-02-17 | 0001193125-26-053243 | EDGAR | 1K words |
| 2026-02-12 | 0001193125-26-049005 | EDGAR | 10K words |
| 2025-12-30 | 0001193125-25-335761 | EDGAR | 8K words |
| 2025-12-05 | 0001193125-25-309593 | EDGAR | 1K words |
| 2025-11-18 | 0001193125-25-286424 | EDGAR | 1K words |
| 2025-10-30 | 0001193125-25-258474 | EDGAR | 1K words |
| 2025-09-15 | 0001193125-25-203520 | EDGAR | 1K words |
361 total filings indexed. 329 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001262104 |
| Ticker | LITS |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.litestrategy.com |
| Listed | 2003-12-18 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/LITS (~200 tokens, structured JSON with cryptographic provenance)